‘Science Speaks’ Examines Reaction To Leaked TPP Pharmaceutical Chapter, Daraprim Price Increase
Center for Global Health Policy’s “Science Speaks”: “A sweetheart deal” “deplorable” “immoral and unacceptable” “Massive victory for big pharma” … We’re reading about TPP’s pharma rules, and an update on a 5000-percent price hike
Antigone Barton, senior writer and editor of “Science Speaks,” discusses a leaked version of the Trans-Pacific Partnership trade agreement’s pharmaceutical provision, as well as reaction to the leaked chapter. She also writes about some of the consequences of the recent 5,000 percent price increase on Turing Pharmaceuticals’ Daraprim, a treatment for toxoplasmosis (10/20).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.